Our results demonstrated that HE treatment improved IRI-induced renal injury, decreased RF, restored the expression of miR-1271 after IRI, and reduced ERS by decreasing the expression of GRP78 and CHOP. The gene discussed is HSPA5; the disease is hereditary elliptocytosis.